Viral Pharyngitis, Viral Tonsillitis
Conditions
Keywords
Viral pharyngo-tonsillitis;, Herbal medicine;, Traditional medicine;, Aromatic essential oils;
Brief summary
This randomized, double blind, parallel group study, compared the efficacy of spray containing aromatic essential oils of some herbal plants, against placebo in the treatment of patients with acute viral Pharyngo-tonsillitis. Study objectives: Primary to demonstrate a throat pain relief within 20 minutes after first administration of treatment with the spray. Secondary to demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment
Detailed description
This study compared the efficacy of spray containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, against placebo in the treatment of patients with acute viral Pharyngo-tonsillitis. In- vitro and clinical studies suggest therapeutic potential of aromatic herbs and trees oils in the treatment of Pharyngo-Tonsillitis. The pharmacological and clinical activity of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, include anti-inflammatory, anti-bacterial and anti-viral activities. Some of these herbs and trees oils have direct activity on the respiratory tract, the coughing reflex and the airflow in the nasal tract.
Interventions
3% of mixture containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, spraying to the throat.
0:1% of Lemon VIP (Florasynth,Israel), spraying to the throat.
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical diagnosis of acute viral pharyngo-tonsillitis. * Active disease less than 48 hours * Patients agree to sign informed consent according to GCP and Israel national regulations.
Exclusion criteria
* Acute follicular tonsillitis. * Peritonsillar abscess. * Under any antibiotically treatment. * Asthma disease. * Under coumadine therapy. * Hyper sensitivity to Aromatic essential oils. * Any immuno-suppressive disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To demonstrate a throat pain relief within the first 20 minutes after first administration of treatment with the spray. | 20 minutes |
Secondary
| Measure | Time frame |
|---|---|
| To demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment. | 3 days |
Countries
Israel